Our study assessed 112 high-risk breast cancer families for this variant, with our inclusion criteria (see Methods, first inclusion criterion) being similar to those of Kato and colleagues [22] aside from the fact that the BRCA1/2 mutation status was not reported in the Japanese study. Here, BRCA1 is linked to breast carcinoma.